Stocks Overview

LAST PRICE
63.4500
TODAY'S CHANGE (%)
Trending Up0.8900 (1.4226%)

Bid / Lots
62.5400/ 1
Ask / Lots
63.4500/ 3
Open / Previous Close
62.4000 / 62.5600
Day Range
Low 61.4100
High 63.7600
52 Week Range
Low 61.1500
High 99.5600
Volume
1,362,616
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 62.56
Time	Volume	BMRN
09:32 ET	14550	62.445
09:33 ET	5509	62.53
09:35 ET	1319	62.29
09:37 ET	6457	61.94
09:39 ET	7002	62.2
09:42 ET	6563	62.07
09:44 ET	2075	62.01
09:46 ET	3975	62.11
09:48 ET	2632	62.005
09:50 ET	9910	61.9067
09:51 ET	2274	62.04
09:53 ET	2555	61.89
09:55 ET	2684	61.82
09:57 ET	2092	61.75
10:00 ET	2079	61.655
10:02 ET	2015	61.715
10:04 ET	2362	61.6
10:06 ET	3033	61.48
10:08 ET	6884	61.46
10:09 ET	2994	61.55
10:11 ET	17785	61.57
10:13 ET	3185	61.74
10:15 ET	2450	61.87
10:18 ET	1666	61.95
10:20 ET	1611	61.97
10:22 ET	8916	61.72
10:24 ET	1598	61.685
10:26 ET	2565	61.715
10:27 ET	612	61.7
10:29 ET	500	61.71
10:31 ET	1807	61.6
10:33 ET	1496	61.74
10:36 ET	800	61.775
10:38 ET	1399	61.84
10:40 ET	1017	61.825
10:42 ET	1000	61.775
10:44 ET	2220	61.88
10:45 ET	700	61.915
10:47 ET	1632	61.945
10:49 ET	2650	61.96
10:51 ET	2909	62.025
10:54 ET	500	62.07
10:56 ET	1400	62.18
10:58 ET	1051	62.245
11:00 ET	834	62.175
11:02 ET	906	62.2
11:03 ET	1913	62.0798
11:05 ET	814	62.04
11:07 ET	1600	62.12
11:09 ET	2491	62.175
11:12 ET	1050	62.13
11:14 ET	900	62.285
11:16 ET	800	62.28
11:18 ET	6045	62.31
11:20 ET	1940	62.35
11:21 ET	1649	62.265
11:23 ET	300	62.32
11:25 ET	2987	62.37
11:27 ET	1900	62.36
11:30 ET	3147	62.425
11:32 ET	1608	62.42
11:34 ET	920	62.34
11:36 ET	2910	62.455
11:38 ET	1402	62.375
11:39 ET	2799	62.46
11:41 ET	7517	62.6
11:43 ET	2650	62.565
11:45 ET	2133	62.6
11:48 ET	1200	62.54
11:50 ET	1504	62.54
11:52 ET	586	62.52
11:54 ET	500	62.54
11:56 ET	900	62.57
11:57 ET	600	62.565
11:59 ET	800	62.615
12:01 ET	300	62.57
12:03 ET	1032	62.565
12:06 ET	605	62.51
12:08 ET	1207	62.54
12:10 ET	2782	62.5202
12:12 ET	1125	62.5
12:14 ET	700	62.5
12:15 ET	3076	62.5
12:17 ET	800	62.53
12:19 ET	5069	62.63
12:21 ET	1638	62.74
12:24 ET	1300	62.68
12:26 ET	580	62.69
12:28 ET	1203	62.7184
12:30 ET	1365	62.74
12:32 ET	3705	62.76
12:33 ET	3236	62.75
12:35 ET	1701	62.74
12:37 ET	5142	62.745
12:39 ET	800	62.75
12:42 ET	4528	62.84
12:44 ET	2280	62.86
12:46 ET	1500	62.935
12:48 ET	1564	63.01
12:50 ET	7589	63.13
12:51 ET	1200	63.15
12:53 ET	3710	63.175
12:55 ET	1438	63.22
12:57 ET	1935	63.21
01:00 ET	2899	63.125
01:02 ET	1700	63.16
01:04 ET	2930	63.16
01:06 ET	2585	63.15
01:08 ET	1500	63.09
01:09 ET	1545	63.12
01:11 ET	1100	63.12
01:13 ET	4351	63.1506
01:15 ET	1754	63.15
01:18 ET	2054	63.13
01:20 ET	2093	63.17
01:22 ET	2901	63.2
01:24 ET	598	63.32
01:26 ET	3609	63.28
01:27 ET	2347	63.295
01:29 ET	2637	63.2
01:31 ET	2233	63.29
01:33 ET	4625	63.25
01:36 ET	7164	63.255
01:38 ET	2100	63.36
01:40 ET	6373	63.39
01:42 ET	7056	63.45
01:44 ET	3487	63.445
01:45 ET	3943	63.445
01:47 ET	5252	63.45
01:49 ET	3428	63.355
01:51 ET	1857	63.36
01:54 ET	5762	63.39
01:56 ET	2348	63.4
01:58 ET	3307	63.355
02:00 ET	5199	63.27
02:02 ET	5340	63.34
02:03 ET	3100	63.33
02:05 ET	3760	63.38
02:07 ET	1879	63.36
02:09 ET	2794	63.28
02:12 ET	2790	63.205
02:14 ET	2772	63.105
02:16 ET	1877	63.12
02:18 ET	1300	63.205
02:20 ET	2231	63.135
02:21 ET	2283	63.133
02:23 ET	1700	63.145
02:25 ET	3371	63.22
02:27 ET	1605	63.22
02:30 ET	1324	63.19
02:32 ET	2227	63.18
02:34 ET	1776	63.19
02:36 ET	2811	63.14
02:38 ET	2150	63.14
02:39 ET	1366	63.22
02:41 ET	5246	63.26
02:43 ET	3606	63.28
02:45 ET	5725	63.32
02:48 ET	7405	63.42
02:50 ET	2154	63.29
02:52 ET	7014	63.37
02:54 ET	5493	63.44
02:56 ET	3393	63.52
02:57 ET	9023	63.57
02:59 ET	5277	63.46
03:01 ET	3786	63.46
03:03 ET	3311	63.43
03:06 ET	2420	63.455
03:08 ET	3889	63.49
03:10 ET	4110	63.55
03:12 ET	6016	63.55
03:14 ET	6240	63.61
03:15 ET	3209	63.635
03:17 ET	5130	63.685
03:19 ET	5868	63.72
03:21 ET	2655	63.76
03:24 ET	3904	63.615
03:26 ET	2598	63.625
03:28 ET	5308	63.67
03:30 ET	2100	63.64
03:32 ET	2473	63.55
03:33 ET	2803	63.545
03:35 ET	5196	63.59
03:37 ET	2703	63.59
03:39 ET	3151	63.45
03:42 ET	9272	63.525
03:44 ET	2771	63.52
03:46 ET	3200	63.535
03:48 ET	4677	63.56
03:50 ET	3994	63.49
03:51 ET	7456	63.515
03:53 ET	4244	63.51
03:55 ET	6363	63.44
03:57 ET	19517	63.44
04:00 ET	232005	63.45

Data delayed at least 15 minutes.

Nov 16, 2024
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by Dow Jones
  10:45AM ET on Saturday Nov 16, 2024 by Dow Jones
Nov 15, 2024
- DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones
  5:26AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 6, 2024
- BioMarin to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 30, 2024
- DJ BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup, from 2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones
  2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones
- DJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesBMRN BioMarin Pharmaceutical Inc	11.9B	38.2x	---
United StatesEXAS Exact Sciences Corp	9.8B	-45.3x	---
United StatesNBIX Neurocrine Biosciences Inc	12.5B	33.5x	+62.04%
United StatesMEDP Medpace Holdings Inc	10.1B	29.9x	+35.10%
United StatesUTHR United Therapeutics Corp	16.3B	16.1x	+8.22%
United StatesQGEN Qiagen NV	9.4B	103.8x	+12.66%
As of 2024-11-22

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.

Contact Information

Headquarters: 105 Digital DriveNOVATO, CA, United States 94949
Phone: 415-505-6700
Fax: 415-382-7889

Executives

Non-Executive Independent Chairman of the Board: Richard Meier
President, Chief Executive Officer, Director: Alexander Hardy
Acting Chief Financial Officer, Senior Vice President, Chief Accounting Officer: Brian Mueller
President - Worldwide Research and Development: Henry Fuchs
Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer: C. Greg Guyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$11.9B
Revenue (TTM)	$2.8B
Shares Outstanding	190.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.29
EPS	$1.66
Book Value	$26.25
P/E Ratio	38.2x
Price/Sales (TTM)	4.3
Price/Cash Flow (TTM)	28.3x
Operating Margin	11.81%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

BioMarin Pharmaceutical Inc
NASDAQ:BMRNUnited States

Search Criteria

Charts

Recent News

Nov 16, 2024

BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by Dow Jones

Nov 15, 2024

DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 6, 2024

BioMarin to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Oct 30, 2024

DJ BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup, from 2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar